©Pixabay

A pioneering new clinical collaboration between a Cambridge start-up specialised in gut bacteria, and Cancer Care UK, is hoping to transform the approach to treating malignant tumours. Founded in 2016, Microbiotica has received backing from several venture capital funds to conduct its research trials with Cambridge University Hospitals.

Get full access to our archive by becoming a member of Innovation Origins. Sign up here as a supporter of independent journalism!

Become a member!

On Innovation Origins you can read the latest news about the world of innovation every day. We want to keep it that way, but we can't do it alone! Are you enjoying our articles and would you like to support independent journalism? Become a member and read our stories guaranteed ad-free.

About the author

Author profile picture